The Trump administration disbanded a federal newborn screening panel. Advocates now face a harder pathnews2025-07-15T13:30:58+00:00July 15th, 2025|Endpoints News|
Judge rejects AbbVie’s fight against Missouri 340B contract pharmacy lawnews2025-07-14T19:50:02+00:00July 14th, 2025|Endpoints News|
#IAS25: WHO adds Gilead’s twice-yearly injection to global PrEP guidelinesnews2025-07-14T13:52:40+00:00July 14th, 2025|Endpoints News|
#IAS25: Merck sends new monthly oral PrEP to Phase 3 after earlier islatravir setbacknews2025-07-14T13:30:09+00:00July 14th, 2025|Endpoints News|
#IAS25: GSK’s ViiV expands licensing pact to include long-acting HIV treatmentnews2025-07-14T13:00:09+00:00July 14th, 2025|Endpoints News|
AstraZeneca blood pressure pill succeeds in pivotal trial, validating CinCor dealnews2025-07-14T11:18:46+00:00July 14th, 2025|Endpoints News|
Restrictions on Valneva’s chikungunya shot lifted in Europenews2025-07-11T17:35:22+00:00July 11th, 2025|Endpoints News|
Novartis dealt a blow in patent fight to block Entresto genericsnews2025-07-11T17:24:07+00:00July 11th, 2025|Endpoints News|
FDA’s Makary floats idea of fast-review vouchers in return for lower US pricesnews2025-07-11T16:53:41+00:00July 11th, 2025|Endpoints News|
UK clears Bayer’s hot flash treatment, marking first approval worldwidenews2025-07-11T15:25:06+00:00July 11th, 2025|Endpoints News|
